JPMorgan Chase & Co’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $38.5K | Buy |
|
|||||
|
2025
Q1 | $17.5K | Sell |
|
|||||
|
2024
Q4 | $3.62M | Buy |
|
|||||
|
2024
Q3 | $4.44M | Buy |
|
|||||
|
2024
Q2 | $3.97M | Buy |
|
|||||
|
2024
Q1 | $6.39M | Buy |
|
|||||
|
2023
Q4 | $183K | Sell |
|
|||||
|
2023
Q3 | $339K | Sell |
|
|||||
|
2023
Q2 | $4.75M | Buy |
|
|||||
|
2023
Q1 | $500K | Sell |
|
|||||
|
2022
Q4 | $2.27M | Buy |
|
|||||
|
2022
Q3 | $406K | Sell |
|
|||||
|
2022
Q2 | $2.08M | Buy |
|
|||||
|
2022
Q1 | $1.24M | Buy |
|
|||||
|
2021
Q4 | $197K | Buy |
|
|||||
|
2021
Q3 | $297K | Buy |
|
|||||
|
2021
Q2 | $405K | Sell |
|
|||||
|
2021
Q1 | $2.3M | Sell |
|
|||||
|
2020
Q4 | $4.63M | Sell |
|
|||||
|
2020
Q3 | $3.89M | Sell |
|
|||||
|
2020
Q2 | $5.26M | Sell |
|
|||||
|
2020
Q1 | $2.6M | Sell |
|
|||||
|
2019
Q4 | $3.89M | Sell |
|
|||||
|
2019
Q3 | $1.47M | Buy |
|
|||||
|
2019
Q2 | $3.32M | Sell |
|
|||||
|
2019
Q1 | $4.33M | Buy |
|
|||||
|
2018
Q4 | $1.73M | Buy |
|
|||||
|
2018
Q3 | $3.18M | Buy |
|
|||||
|
2018
Q2 | $5.26M | Sell |
|
|||||
|
2018
Q1 | $4.86M | Sell |
|
|||||
|
2017
Q4 | $5.48M | Sell |
|
|||||
|
2017
Q3 | $5.86M | Sell |
|
|||||
|
2017
Q2 | $4.76M | Buy |
|